Arrow Contemplates Fate Of LVAD Business; WorldHeart, Thoratec Start Trials
This article was originally published in The Gray Sheet
Executive Summary
Arrow International's board of directors will assess the future commercial potential of its left-ventricular assist devices at a meeting April 6-7